From filing to price impact: microstructure, currency-normalised comparisons, walk-forward design.
Tikehau Capital’s insider buying cluster comes as private credit and thematic strategies keep the Paris manager’s H1 momentum alive.
Sanofi’s August 24 executive buys land after stronger Q2 guidance and a firmer Paris share price. Here is what the cluster adds, and what it does not.
Hexagon’s board buy lands after 12% organic growth, a stronger Q2 and a recent insider cluster. Here is what the filing adds, and what it does not.
Alibaba directors bought after a mixed Q1: cloud grew 45%, capex jumped 75%, and the stock still trades against PDD and JD.
Amotiv director Jennifer Anne Douglas bought EUR 12,040 after FY26 shares fell 14%. Read the cluster, the outlook, and the sector backdrop.
Deutsche Bank trades near €32.50 while the July 29 buyback and a strong European bank backdrop keep the stock in focus, with no fresh insider prints.
Bayer trades near €48 as Roundup timing, Q2 progress and a quiet insider tape keep the legal discount in focus versus Pfizer.
BASF is leaning on buybacks, specialty price hikes and portfolio exits while Rhine logistics stay awkward. The insider record is quiet.
Allianz held near 440.80 euros after a record Q2. Munich Re’s latest beat sets the peer backdrop, while insider filings stay quiet.
BNP Paribas rose after a 33% profit jump and a strong bank tape. The catch is simple: no fresh insider trades, only a modest 90-day buy tally.
Mandatum drew a clustered insider buy after Altor sold out. The stock sits near EUR 6.11 to 6.27, with wealth management momentum still doing the heavy lifting.
Fabege insiders bought through August as Stockholm property stayed soft. Here is what the cluster says, and where the case breaks down.